Joseph R. McGill
-
- Hemophilia Treatment and Research 5
- Platelet Disorders and Treatments 3
-
- vaccines and immunoinformatics approaches 4
- CRISPR and Genetic Engineering 3
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Biosimilars and Bioanalytical Methods 3
-
- Cancer, Hypoxia, and Metabolism 2
- MicroRNA in disease regulation 2
- Co-authors
- Zuben E. SaunaVijaya L. SimhadriHaiyan JiangJunxia WangShane McMahonOsman N. YoğurtçuHong YangBehnaz Pezeshkpoor
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
Joseph R. McGill
18 papers receiving 341 citations
Peers
Comparison fields: 5 of 54
- Business and International Management 21
- Aging 9
- Hematology 54
- Molecular Biology 266
- Oncology 76
Countries citing papers authored by Joseph R. McGill
This map shows the geographic impact of Joseph R. McGill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph R. McGill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph R. McGill more than expected).
Fields of papers citing papers by Joseph R. McGill
This network shows the impact of papers produced by Joseph R. McGill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph R. McGill. The network helps show where Joseph R. McGill may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joseph R. McGill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 3 | |
| 2 | 2022 | 5 | |
| 3 | 2022 | 7 | |
| 4 | 2021 | 13 | |
| 5 | 2021 | 9 | |
| 6 | 2021 | 10 | |
| 7 | 2021 | 2 | |
| 8 | 2020 | 17 | |
| 9 | 2020 | 9 | |
| 10 | 2020 | 7 | |
| 11 | 2019 | 3 | |
| 12 | 2019 | 15 | |
| 13 | 2019 | 7 | |
| 14 | 2019 | 20 | |
| 15 | 2019 | 8 | |
| 16 | 2019 | 9 | |
| 17 | 2019 | 23 | |
| 18 | 2018 | 183 |
About Joseph R. McGill
Joseph R. McGill is a scholar working on Hematology, Cancer Research and Immunology, having authored 18 papers that have together received 350 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Hemophilia Treatment and Research (5 papers), vaccines and immunoinformatics approaches (4 papers), Platelet Disorders and Treatments (3 papers), CRISPR and Genetic Engineering (3 papers), Biosimilars and Bioanalytical Methods (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Business and International Management (21 citations), Aging (9 citations) and Hematology (54 citations). Joseph R. McGill has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Zuben E. Sauna, Vijaya L. Simhadri, Haiyan Jiang, Junxia Wang, Shane McMahon, Osman N. Yoğurtçu, Hong Yang, Behnaz Pezeshkpoor, Johannes Oldenburg and Chintamani D. Atreya. Their work appears in journals such as Blood Advances, Scientific Reports, Transfusion, Frontiers in Cell and Developmental Biology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.